07214143falsemanufacture and storage of vitamin and mineral supplements2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/pt:ShareCapital2022-01-31http://www.companieshouse.gov.uk/cd:Director12022-02-012023-01-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-01-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12022-02-012023-01-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2022-02-012023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2022-01-31http://www.companieshouse.gov.uk/2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/cd:FRS1022022-02-012023-01-31http://www.companieshouse.gov.uk/2023-01-31http://www.companieshouse.gov.uk/cd:FullAccounts2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2022-02-012023-01-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 07214143

Nutripharm Limited

ACCOUNTS
FOR THE YEAR ENDED 31/01/2023

Prepared By:
N B Lancaster & Co
Chartered Accountants
6 Brunswick Street
Carlisle
Cumbria
CA1 1PN

Nutripharm Limited

ACCOUNTS
FOR THE YEAR ENDED 31/01/2023
DIRECTORS
P T Jobson
REGISTERED OFFICE
7 Lansdowne Court
Carlisle
Cumbria
CA3 9HW
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 07214143
BANKERS
The Cumberland Building Society
ACCOUNTANTS
N B Lancaster & Co
Chartered Accountants
6 Brunswick Street
Carlisle
Cumbria
CA1 1PN

Nutripharm Limited

ACCOUNTS
FOR THEYEARENDED31/01/2023
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

Nutripharm Limited

BALANCE SHEET AT 31/01/2023
20232022
Notes££
FIXED ASSETS
Tangible assets217,55422,913
CURRENT ASSETS
Stock7,5657,520
Debtors47,13010,572
Cash at bank and in hand48,88426,418
63,57944,510
CREDITORS: Amounts falling due within one year5111,55294,597
NET CURRENT LIABILITIES(47,973)(50,087)
TOTAL ASSETS LESS CURRENT LIABILITIES(30,419)(27,174)
CAPITAL AND RESERVES
Called up share capital7100100
Profit and loss account(30,519)(27,274)
SHAREHOLDERS' FUNDS(30,419)(27,174)
For the year ending 31/01/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 13/10/2023 and signed on their behalf by
.............................
P T Jobson
Director

Nutripharm Limited

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/01/2023
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Plant and Machineryreducing balance 25%
Fixtures and Fittingsreducing balance 15%
Equipmentreducing balance 25%
1c. Stocks
Stocks are valued at the lower of cost and net estimated selling price less selling costs. Cost is based on average cost. For work in progress, cost is taken as the production cost which includes a proportion of attributable overheads.
1d. Government Grants
1e. Taxation
Taxation represents the sum of tax currently payable and deferred tax. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
1f. Turnover
Turnover represents the invoiced value of goods and services supplied by the company, net of value added tax and trade discounts. Turnover is recognised upon the despatch of goods or the provision of services.

Nutripharm Limited

2. TANGIBLE FIXED ASSETS
Plant andFixtures
Machineryand FittingsEquipmentTotal
££££
Cost
At 01/02/202272,8926,55075880,200
Additions-315-315
At 31/01/202372,8926,86575880,515
Depreciation
At 01/02/202251,1385,52562457,287
For the year5,439201345,674
At 31/01/202356,5775,72665862,961
Net Book Amounts
At 31/01/202316,3151,13910017,554
At 31/01/202221,7541,02513422,913
3. STOCK 20232022
££
Stock comprises:
Stock45-
Work in progress7,5207,520
7,5657,520
4. DEBTORS 20232022
££
Amounts falling due within one year
Trade debtors2,455-
UK corporation tax2,9177,597
VAT1,7582,975
7,13010,572

Nutripharm Limited

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20232022
££
Directors current account75,55257,397
Other creditors35,00035,000
Accruals1,0002,200
111,55294,597
6. EMPLOYEES
20232022
No.No.
Average number of employees11
7. SHARE CAPITAL 20232022
££
Allotted, issued and fully paid:
100 Ordinary shares of £1 each100100
100100
8. RELATED PARTY TRANSACTIONS
At the balance sheet date the company owed £75,552 (2022 - £57,397) to the director. The loan is unsecured, interest free and repayable on demand.
The director received a salary of £9,054 during the year (2022 - £8,834).
9. ADDITIONAL INFORMATION
The company is a private company, reistered in England & Wales and limited by shares.
The company's registered number is 07214143.
The company's registered office is 7 Lansdowne Court, Carlisle, CA3 9HW.